The Technical Analyst
Select Language :
Cogint Inc. [COGT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Cogint Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Cogint Inc. is listed at the  Exchange

3.07% $6.72

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 698.30 mill
EPS: -2.42
P/E: -2.78
Earnings Date: May 07, 2024
SharesOutstanding: 103.91 mill
Avg Daily Volume: 2.23 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.78 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.47x
Company: PE -2.78 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.432
(-93.58%) $-6.29
Date: 2024-03-29
Expected Trading Range (DAY)

$ 6.02 - 7.42

( +/- 10.45%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-16 Fairmount Funds Management Llc Buy 1 166 666 Common Stock
2024-02-16 Fairmount Funds Management Llc Buy 1 500 Series B Convertible Preferred Stock
2024-01-23 Robinson John Edward Buy 300 000 Stock Option (Right to Buy)
2024-01-23 Kearns Evan Buy 255 000 Stock Option (Right to Buy)
2024-01-23 Sachs Jessica Buy 300 000 Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 97 transactions
Buy: 19 240 363 | Sell: 1 265 393

Forecast: 16:00 - $6.72

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $6.72
Forecast 2: 16:00 - $6.72
Forecast 3: 16:00 - $6.72
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $6.72 (3.07% )
Volume 2.07 mill
Avg. Vol. 2.23 mill
% of Avg. Vol 93.07 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Cogint Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Cogint Inc.

RSI

Intraday RSI14 chart for Cogint Inc.

Last 10 Buy & Sell Signals For COGT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$6.32N/AActive
Profile picture for
            Cogint Inc.

COGT

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87
FTNUSDMar 29 - 04:141.819
ORAIUSDMar 29 - 04:0814.59
IONUSDMar 29 - 04:08452.00
MXUSDMar 29 - 04:07$4.21
RETHUSDMar 29 - 04:043 905.62
ABTUSDMar 29 - 04:041.978

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.